Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Sequenom to Develop Third-Generation Nanopore-Based Single Molecule Sequencing Technology

Published: Tuesday, September 25, 2007
Last Updated: Tuesday, September 25, 2007
Bookmark and Share
Company Acquires Rights to DNA and RNA Readout Technology That Holds Potential for Cost-Effective and Ultra Rapid Human Genome Sequencing

Sequenom, Inc. has announced that it plans to develop a third-generation single molecule nucleic acid analysis technology based on exclusive license rights from Harvard University that covers a readout system technology for single DNA molecules based on simultaneous optical probing of multiple nanopores.

This technology recently received a National Institutes of Health (NIH) three-year award for the development of a next-generation sequencing technology aiming at a sub-thousand dollar genome.

Nanopore-based single molecule readout technology is a method that can detect a single strand of DNA as it passes through a pore that is more than a thousand times smaller than the diameter of a human hair and should enable ultra-high throughput DNA analysis such as sequencing, genotyping, and RNA and epigenetic analysis on a whole genome scale.

Financial terms of the agreement include up-front fees, milestone payments and royalties on future product sales.

"We are excited to have an opportunity to collaborate with such world class institutions and researchers in developing this potentially disruptive technology," said Harry Stylli, Ph.D., Chief Executive Officer of Sequenom.

"This technology should enable us to provide highly competitive large-scale genotyping, and RNA analysis and ultimately sequencing-based solutions to the market.

Our MassARRAY® platform is the leading fine mapping/translational solution and as we continue to expand and develop new applications for the platform, we also plan to expand our market penetration into the complementary whole genome analysis/single molecule sequencing markets with this potentially redefining nanopore technology.

Near term we expect this nanopore technology to deliver large scale genotyping solutions and long term we believe it has the potential to provide a commercially viable, rapid, sub-thousand dollar human genome sequencing solution."

"As nucleic acid sequencing costs become progressively lower, it will become cost effective to replace more aspects of DNA and RNA analysis by sequencing," stated Charles Cantor, Ph.D., Chief Scientific Officer of Sequenom.

"It is strategically important for Sequenom to be able to offer customers a cost-effective sequencing option and we do not believe the new second-generation sequencing methods will achieve the needed cost effectiveness," Dr. Cantor added.

"The synergy between the required manpower skills needed to develop nanopore sequencing and our current science and engineering expertise behind our MassARRAY technology is noteworthy.

Optimizing molecular biology tools for sample preparation and optimizing software tools for fast signal processing are key requirements for nanopore sequencing and Sequenom currently has great strength and experience in these areas."

"This Nanopore-based single molecule readout technology combines solid-state nanopores and optical detection to overcome the major challenges associated with directly measuring electrical current differences between traversing molecules, challenges such as the need to wire every single pore and the very high flow rate and electrical noise that can prevent discrimination between single bases.

This technology also avoids the uncertainties associated with the development of new chemical compounds required in other approaches and does not rely on the relatively slow enzymatic incorporation of nucleotides allowing for an extremely high-throughput of millions of bases per second," said inventor and development partner Amit Meller, Ph.D., Associate Professor at the Boston University Department of Biomedical Engineering. Dr. Meller invented the technology while at the Rowland Institute of Harvard University.

"We are delighted that Sequenom will be developing this technology, which may enable the coming revolution in personalized medicine, which will greatly benefit the public's health," said Isaac Kohlberg, Chief Technology Officer of Harvard University and head of Harvard's Office of Technology Development.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Sequenom Announce New Data from a Collaborative Project with The Chinese University of Hong Kong
Next-generation noninvasive diagnostic technology shown to detect fetal down syndrome in first trimester of pregnancy.
Tuesday, December 02, 2008
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Accelerating the Detection of Foodborne Bacterial Outbreaks
The speed of diagnosis of foodborne bacterial outbreaks could be improved by a new technique developed by researchers at the Georgia Institute of Technology.
Top 10 Life Science Innovations of 2016
2016 has seen the release of some truly innovative products. To help you digest these developments, The Scientist have listed their top picks for the year.
Scientists Identify Unique Genomic Features in Testicular Cancer
The findings may shed light on factors in other cancers that influence their sensitivity to chemotherapy.
Secret Phenotypes: Disease Devils in Invisible Details
Algorithmic deep phenotyping exposes masses of hidden traits and possible subtle genetic connections relevant to unseen influences on disease.
Cracking the Code of a Deadly Virus
Researchers have exploited weaknesses in VEEV's genetic code, creating a far less deadly variant.
Hunting the Missing Link Between Genetics and the Environment
The International Phenome Centre Network (IPCN) works to transform healthcare through phenomics - the dynamic interactions between our genes and our environment.
Repurposing Genes for Brain Development
Mammalian bone gene may be repurposed to promote cognition in humans.
Enhancing CRISPR to Explore Further
Researchers have developed sOPTiKO, a more efficient and controllable CRISPR genome editing platform.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!